A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2020-06-27
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, active-controlled, 2 period cross-over clinical trial in
subjects with type 1 diabetes mellitus using a Multiple Daily Injection (MDI) regimen.